<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="https://ontobee.org/ontology/view/CTO?iri=http://purl.obolibrary.org/obo/CTO_0000207"?>
<rdf:RDF xmlns="http://www.w3.org/2002/07/owl#"
     xml:base="http://www.w3.org/2002/07/owl"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:owl="http://www.w3.org/2002/07/owl#"
     xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#"
     xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
     xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
     xmlns:foaf="http://xmlns.com/foaf/0.1/"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:ns3="http://purl.obolibrary.org/obo/">
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Annotation properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    <AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000118"/>
    <AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000117"/>
    <AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000119"/>
    <AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000115"/>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Datatypes
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Object Properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://purl.obolibrary.org/obo/OPMI_0000366 -->

    <ObjectProperty rdf:about="http://purl.obolibrary.org/obo/OPMI_0000366">
        <rdfs:label xml:lang="en">has process quality</rdfs:label>
    </ObjectProperty>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Classes
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://purl.obolibrary.org/obo/CTO_0000202 -->

    <Class rdf:about="http://purl.obolibrary.org/obo/CTO_0000202">
        <rdfs:label>clinical trial early phase 1</rdfs:label>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/CTO_0000207 -->

    <Class rdf:about="http://purl.obolibrary.org/obo/CTO_0000207">
        <rdfs:label xml:lang="en">Early Phase 1 clinical trial</rdfs:label>
        <equivalentClass>
            <Restriction>
                <onProperty rdf:resource="http://purl.obolibrary.org/obo/OPMI_0000366"/>
                <someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/CTO_0000202"/>
            </Restriction>
        </equivalentClass>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/CTO_0000220"/>
        <ns3:IAO_0000118>Phase 0 trial</ns3:IAO_0000118>
        <ns3:IAO_0000119>https://en.wikipedia.org/wiki/Clinical_trial</ns3:IAO_0000119>
        <ns3:IAO_0000119>http://purl.obolibrary.org/obo/NCIT_C54721</ns3:IAO_0000119>
        <ns3:IAO_0000118>Phase 0 clinical trial</ns3:IAO_0000118>
        <ns3:IAO_0000115>A clinical trial that is at Early Phase 1 or Phase 0</ns3:IAO_0000115>
        <ns3:IAO_0000115>Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies). (Formerly listed as &quot;Phase 0&quot;)</ns3:IAO_0000115>
        <ns3:IAO_0000118>Pre-Clinical Trial</ns3:IAO_0000118>
        <ns3:IAO_0000117>Leon Li, Asiyah Lin, Oliver He</ns3:IAO_0000117>
        <ns3:IAO_0000115>A clinical trial that is at an Early Phase i or Phase 0, which is designed to use an investigational agent that is available only in very limited quantities and which has never previously given to humans or for which there is extremely limited human experience. Phase 0 clinical trials are intended to enable researchers to understand the path of the drug in the body and its efficacy. Adverse event reporting in Phase 0 trials is expedited. [def-source: NCI]</ns3:IAO_0000115>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/CTO_0000220 -->

    <Class rdf:about="http://purl.obolibrary.org/obo/CTO_0000220">
        <rdfs:label xml:lang="en">clinical trial</rdfs:label>
    </Class>
</rdf:RDF>



<!-- Generated by the OWL API (version 3.2.4.1806) http://owlapi.sourceforge.net -->



